Wood Screws
The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More
Global Anti-Venom Market Outlook 2023
1 Anti-Venom Market Overview
1.1 Product Overview and Scope of Anti-Venom
1.2 Anti-Venom Segment by Type
1.2.1 Global Anti-Venom Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Polyvalent Anti-Venom
1.2.3 Monovalent Anti-Venom
1.3 Anti-Venom Segment by Application
1.3.1 Global Anti-Venom Sales Comparison by Application: (2021-2027)
1.3.2 Non-profit Institutions
1.3.3 Hospitals and Clinic
1.4 Global Anti-Venom Market Size Estimates and Forecasts
1.4.1 Global Anti-Venom Revenue 2016-2027
1.4.2 Global Anti-Venom Sales 2016-2027
1.4.3 Anti-Venom Market Size by Region: 2016 Versus 2021 Versus 2027
2 Anti-Venom Market Competition by Manufacturers
2.1 Global Anti-Venom Sales Market Share by Manufacturers (2016-2021)
2.2 Global Anti-Venom Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Anti-Venom Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Anti-Venom Manufacturing Sites, Area Served, Product Type
2.5 Anti-Venom Market Competitive Situation and Trends
2.5.1 Anti-Venom Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Anti-Venom Players Market Share by Revenue
2.5.3 Global Anti-Venom Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Anti-Venom Retrospective Market Scenario by Region
3.1 Global Anti-Venom Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Anti-Venom Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Anti-Venom Market Facts & Figures by Country
3.3.1 North America Anti-Venom Sales by Country
3.3.2 North America Anti-Venom Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Anti-Venom Market Facts & Figures by Country
3.4.1 Europe Anti-Venom Sales by Country
3.4.2 Europe Anti-Venom Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Anti-Venom Market Facts & Figures by Region
3.5.1 Asia Pacific Anti-Venom Sales by Region
3.5.2 Asia Pacific Anti-Venom Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Anti-Venom Market Facts & Figures by Country
3.6.1 Latin America Anti-Venom Sales by Country
3.6.2 Latin America Anti-Venom Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Anti-Venom Market Facts & Figures by Country
3.7.1 Middle East and Africa Anti-Venom Sales by Country
3.7.2 Middle East and Africa Anti-Venom Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Anti-Venom Historic Market Analysis by Type
4.1 Global Anti-Venom Sales Market Share by Type (2016-2021)
4.2 Global Anti-Venom Revenue Market Share by Type (2016-2021)
4.3 Global Anti-Venom Price by Type (2016-2021)
5 Global Anti-Venom Historic Market Analysis by Application
5.1 Global Anti-Venom Sales Market Share by Application (2016-2021)
5.2 Global Anti-Venom Revenue Market Share by Application (2016-2021)
5.3 Global Anti-Venom Price by Application (2016-2021)
6 Key Companies Profiled
6.1 CSL
6.1.1 CSL Corporation Information
6.1.2 CSL Description and Business Overview
6.1.3 CSL Anti-Venom Sales, Revenue and Gross Margin (2016-2021)
6.1.4 CSL Anti-Venom Product Portfolio
6.1.5 CSL Recent Developments/Updates
6.2 Merck
6.2.1 Merck Corporation Information
6.2.2 Merck Description and Business Overview
6.2.3 Merck Anti-Venom Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Merck Anti-Venom Product Portfolio
6.2.5 Merck Recent Developments/Updates
6.3 BTG
6.3.1 BTG Corporation Information
6.3.2 BTG Description and Business Overview
6.3.3 BTG Anti-Venom Sales, Revenue and Gross Margin (2016-2021)
6.3.4 BTG Anti-Venom Product Portfolio
6.3.5 BTG Recent Developments/Updates
6.4 Pfizer
6.4.1 Pfizer Corporation Information
6.4.2 Pfizer Description and Business Overview
6.4.3 Pfizer Anti-Venom Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Pfizer Anti-Venom Product Portfolio
6.4.5 Pfizer Recent Developments/Updates
6.5 Haffkine Bio-Pharmaceutical
6.5.1 Haffkine Bio-Pharmaceutical Corporation Information
6.5.2 Haffkine Bio-Pharmaceutical Description and Business Overview
6.5.3 Haffkine Bio-Pharmaceutical Anti-Venom Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Haffkine Bio-Pharmaceutical Anti-Venom Product Portfolio
6.5.5 Haffkine Bio-Pharmaceutical Recent Developments/Updates
6.6 Rare Disease Therapeutics
6.6.1 Rare Disease Therapeutics Corporation Information
6.6.2 Rare Disease Therapeutics Description and Business Overview
6.6.3 Rare Disease Therapeutics Anti-Venom Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Rare Disease Therapeutics Anti-Venom Product Portfolio
6.6.5 Rare Disease Therapeutics Recent Developments/Updates
6.7 Flynn Pharma
6.6.1 Flynn Pharma Corporation Information
6.6.2 Flynn Pharma Description and Business Overview
6.6.3 Flynn Pharma Anti-Venom Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Flynn Pharma Anti-Venom Product Portfolio
6.7.5 Flynn Pharma Recent Developments/Updates
6.8 Vins Bioproducts
6.8.1 Vins Bioproducts Corporation Information
6.8.2 Vins Bioproducts Description and Business Overview
6.8.3 Vins Bioproducts Anti-Venom Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Vins Bioproducts Anti-Venom Product Portfolio
6.8.5 Vins Bioproducts Recent Developments/Updates
6.9 Bharat Serums and Vaccines
6.9.1 Bharat Serums and Vaccines Corporation Information
6.9.2 Bharat Serums and Vaccines Description and Business Overview
6.9.3 Bharat Serums and Vaccines Anti-Venom Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Bharat Serums and Vaccines Anti-Venom Product Portfolio
6.9.5 Bharat Serums and Vaccines Recent Developments/Updates
6.10 Serum Biotech
6.10.1 Serum Biotech Corporation Information
6.10.2 Serum Biotech Description and Business Overview
6.10.3 Serum Biotech Anti-Venom Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Serum Biotech Anti-Venom Product Portfolio
6.10.5 Serum Biotech Recent Developments/Updates
6.11 MicroPharm
6.11.1 MicroPharm Corporation Information
6.11.2 MicroPharm Anti-Venom Description and Business Overview
6.11.3 MicroPharm Anti-Venom Sales, Revenue and Gross Margin (2016-2021)
6.11.4 MicroPharm Anti-Venom Product Portfolio
6.11.5 MicroPharm Recent Developments/Updates
7 Anti-Venom Manufacturing Cost Analysis
7.1 Anti-Venom Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Anti-Venom
7.4 Anti-Venom Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Anti-Venom Distributors List
8.3 Anti-Venom Customers
9 Anti-Venom Market Dynamics
9.1 Anti-Venom Industry Trends
9.2 Anti-Venom Growth Drivers
9.3 Anti-Venom Market Challenges
9.4 Anti-Venom Market Restraints
10 Global Market Forecast
10.1 Anti-Venom Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Anti-Venom by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Anti-Venom by Type (2022-2027)
10.2 Anti-Venom Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Anti-Venom by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Anti-Venom by Application (2022-2027)
10.3 Anti-Venom Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Anti-Venom by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Anti-Venom by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Anti-Venom Sales (K Vials) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Anti-Venom Sales (K Vials) Comparison by Application (2021-2027)
Table 3. Global Anti-Venom Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Anti-Venom Covered in This Study
Table 5. Global Anti-Venom Sales (K Vials) of Key Manufacturers (2016-2021)
Table 6. Global Anti-Venom Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Anti-Venom Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Anti-Venom Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Anti-Venom Average Price (USD/Vial) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Anti-Venom Manufacturing Sites and Area Served
Table 11. Manufacturers Anti-Venom Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Anti-Venom by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-Venom as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Anti-Venom Sales by Region (2016-2021) & (K Vials)
Table 16. Global Anti-Venom Sales Market Share by Region (2016-2021)
Table 17. Global Anti-Venom Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Anti-Venom Sales by Country (2016-2021) & (K Vials)
Table 19. North America Anti-Venom Sales Market Share by Country (2016-2021)
Table 20. North America Anti-Venom Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Anti-Venom Revenue Market Share by Country (2016-2021)
Table 22. Europe Anti-Venom Sales by Country (2016-2021) & (K Vials)
Table 23. Europe Anti-Venom Sales Market Share by Country (2016-2021)
Table 24. Europe Anti-Venom Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Anti-Venom Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Anti-Venom Sales by Region (2016-2021) & (K Vials)
Table 27. Asia Pacific Anti-Venom Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Anti-Venom Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Anti-Venom Revenue Market Share by Region (2016-2021)
Table 30. Latin America Anti-Venom Sales by Country (2016-2021) & (K Vials)
Table 31. Latin America Anti-Venom Sales Market Share by Country (2016-2021)
Table 32. Latin America Anti-Venom Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Anti-Venom Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Anti-Venom Sales by Country (2016-2021) & (K Vials)
Table 35. Middle East and Africa Anti-Venom Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Anti-Venom Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Anti-Venom Revenue Market Share by Country (2016-2021)
Table 38. Global Anti-Venom Sales (K Vials) by Type (2016-2021)
Table 39. Global Anti-Venom Sales Market Share by Type (2016-2021)
Table 40. Global Anti-Venom Revenue (Million US$) by Type (2016-2021)
Table 41. Global Anti-Venom Revenue Share by Type (2016-2021)
Table 42. Global Anti-Venom Price (USD/Vial) by Type (2016-2021)
Table 43. Global Anti-Venom Sales (K Vials) by Application (2016-2021)
Table 44. Global Anti-Venom Sales Market Share by Application (2016-2021)
Table 45. Global Anti-Venom Revenue (Million US$) by Application (2016-2021)
Table 46. Global Anti-Venom Revenue Share by Application (2016-2021)
Table 47. Global Anti-Venom Price (USD/Vial) by Application (2016-2021)
Table 48. CSL Corporation Information
Table 49. CSL Description and Business Overview
Table 50. CSL Anti-Venom Sales (K Vials), Revenue (Million US$), Price (USD/Vial) and Gross Margin (2016-2021)
Table 51. CSL Anti-Venom Product
Table 52. CSL Recent Developments/Updates
Table 53. Merck Corporation Information
Table 54. Merck Description and Business Overview
Table 55. Merck Anti-Venom Sales (K Vials), Revenue (Million US$), Price (USD/Vial) and Gross Margin (2016-2021)
Table 56. Merck Anti-Venom Product
Table 57. Merck Recent Developments/Updates
Table 58. BTG Corporation Information
Table 59. BTG Description and Business Overview
Table 60. BTG Anti-Venom Sales (K Vials), Revenue (Million US$), Price (USD/Vial) and Gross Margin (2016-2021)
Table 61. BTG Anti-Venom Product
Table 62. BTG Recent Developments/Updates
Table 63. Pfizer Corporation Information
Table 64. Pfizer Description and Business Overview
Table 65. Pfizer Anti-Venom Sales (K Vials), Revenue (Million US$), Price (USD/Vial) and Gross Margin (2016-2021)
Table 66. Pfizer Anti-Venom Product
Table 67. Pfizer Recent Developments/Updates
Table 68. Haffkine Bio-Pharmaceutical Corporation Information
Table 69. Haffkine Bio-Pharmaceutical Description and Business Overview
Table 70. Haffkine Bio-Pharmaceutical Anti-Venom Sales (K Vials), Revenue (Million US$), Price (USD/Vial) and Gross Margin (2016-2021)
Table 71. Haffkine Bio-Pharmaceutical Anti-Venom Product
Table 72. Haffkine Bio-Pharmaceutical Recent Developments/Updates
Table 73. Rare Disease Therapeutics Corporation Information
Table 74. Rare Disease Therapeutics Description and Business Overview
Table 75. Rare Disease Therapeutics Anti-Venom Sales (K Vials), Revenue (Million US$), Price (USD/Vial) and Gross Margin (2016-2021)
Table 76. Rare Disease Therapeutics Anti-Venom Product
Table 77. Rare Disease Therapeutics Recent Developments/Updates
Table 78. Flynn Pharma Corporation Information
Table 79. Flynn Pharma Description and Business Overview
Table 80. Flynn Pharma Anti-Venom Sales (K Vials), Revenue (Million US$), Price (USD/Vial) and Gross Margin (2016-2021)
Table 81. Flynn Pharma Anti-Venom Product
Table 82. Flynn Pharma Recent Developments/Updates
Table 83. Vins Bioproducts Corporation Information
Table 84. Vins Bioproducts Description and Business Overview
Table 85. Vins Bioproducts Anti-Venom Sales (K Vials), Revenue (Million US$), Price (USD/Vial) and Gross Margin (2016-2021)
Table 86. Vins Bioproducts Anti-Venom Product
Table 87. Vins Bioproducts Recent Developments/Updates
Table 88. Bharat Serums and Vaccines Corporation Information
Table 89. Bharat Serums and Vaccines Description and Business Overview
Table 90. Bharat Serums and Vaccines Anti-Venom Sales (K Vials), Revenue (Million US$), Price (USD/Vial) and Gross Margin (2016-2021)
Table 91. Bharat Serums and Vaccines Anti-Venom Product
Table 92. Bharat Serums and Vaccines Recent Developments/Updates
Table 93. Serum Biotech Corporation Information
Table 94. Serum Biotech Description and Business Overview
Table 95. Serum Biotech Anti-Venom Sales (K Vials), Revenue (Million US$), Price (USD/Vial) and Gross Margin (2016-2021)
Table 96. Serum Biotech Anti-Venom Product
Table 97. Serum Biotech Recent Developments/Updates
Table 98. MicroPharm Corporation Information
Table 99. MicroPharm Description and Business Overview
Table 100. MicroPharm Anti-Venom Sales (K Vials), Revenue (Million US$), Price (USD/Vial) and Gross Margin (2016-2021)
Table 101. MicroPharm Anti-Venom Product
Table 102. MicroPharm Recent Developments/Updates
Table 103. Production Base and Market Concentration Rate of Raw Material
Table 104. Key Suppliers of Raw Materials
Table 105. Anti-Venom Distributors List
Table 106. Anti-Venom Customers List
Table 107. Anti-Venom Market Trends
Table 108. Anti-Venom Growth Drivers
Table 109. Anti-Venom Market Challenges
Table 110. Anti-Venom Market Restraints
Table 111. Global Anti-Venom Sales Forecast by Type (2022-2027) & (K Vials)
Table 112. Global Anti-Venom Sales Market Share Forecast by Type (2022-2027)
Table 113. Global Anti-Venom Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 114. Global Anti-Venom Revenue Market Share Forecast by Type (2022-2027)
Table 115. Global Anti-Venom Sales Forecast by Application (2022-2027) & (K Vials)
Table 116. Global Anti-Venom Sales Market Share Forecast by Application (2022-2027)
Table 117. Global Anti-Venom Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 118. Global Anti-Venom Revenue Market Share Forecast by Application (2022-2027)
Table 119. Global Anti-Venom Sales Forecast by Region (2022-2027) & (K Vials)
Table 120. Global Anti-Venom Sales Market Share Forecast by Region (2022-2027)
Table 121. Global Anti-Venom Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 122. Global Anti-Venom Revenue Market Share Forecast by Region (2022-2027)
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Anti-Venom
Figure 2. Global Anti-Venom Market Share by Type in 2020 & 2027
Figure 3. Polyvalent Anti-Venom Product Picture
Figure 4. Monovalent Anti-Venom Product Picture
Figure 5. Global Anti-Venom Market Share by Application in 2020 & 2027
Figure 6. Non-profit Institutions
Figure 7. Hospitals and Clinic
Figure 8. Global Anti-Venom Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 9. Global Anti-Venom Market Size 2016-2027 (US$ Million)
Figure 10. Global Anti-Venom Sales 2016-2027 (K Vials)
Figure 11. Global Anti-Venom Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 12. Anti-Venom Sales Share by Manufacturers in 2020
Figure 13. Global Anti-Venom Revenue Share by Manufacturers in 2020
Figure 14. The Global 5 and 10 Largest Anti-Venom Players: Market Share by Revenue in 2020
Figure 15. Anti-Venom Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 16. Global Anti-Venom Sales Market Share by Region (2016-2021)
Figure 17. Global Anti-Venom Sales Market Share by Region in 2020
Figure 18. Global Anti-Venom Revenue Market Share by Region (2016-2021)
Figure 19. Global Anti-Venom Revenue Market Share by Region in 2020
Figure 20. U.S. Anti-Venom Revenue Growth Rate (2016-2021) (US$ Million)
Figure 21. Canada Anti-Venom Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Germany Anti-Venom Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. France Anti-Venom Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. U.K. Anti-Venom Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Italy Anti-Venom Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Russia Anti-Venom Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. China Anti-Venom Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Japan Anti-Venom Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. South Korea Anti-Venom Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. India Anti-Venom Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Australia Anti-Venom Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Taiwan Anti-Venom Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Indonesia Anti-Venom Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Thailand Anti-Venom Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Malaysia Anti-Venom Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Philippines Anti-Venom Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Vietnam Anti-Venom Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Mexico Anti-Venom Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Brazil Anti-Venom Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Argentina Anti-Venom Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Turkey Anti-Venom Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Saudi Arabia Anti-Venom Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. UAE Anti-Venom Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Sales Market Share of Anti-Venom by Type (2016-2021)
Figure 45. Sales Market Share of Anti-Venom by Application (2016-2021)
Figure 46. Sales Market Share of Anti-Venom by Application in 2020
Figure 47. Revenue Share of Anti-Venom by Application (2016-2021)
Figure 48. Revenue Share of Anti-Venom by Application in 2020
Figure 49. Manufacturing Cost Structure of Anti-Venom
Figure 50. Manufacturing Process Analysis of Anti-Venom
Figure 51. Anti-Venom Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
CSL Merck BTG Pfizer Haffkine Bio-Pharmaceutical Rare Disease Therapeutics Flynn Pharma Vins Bioproducts Bharat Serums and Vaccines Serum Biotech MicroPharm